Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Change in Account Payables (2017 - 2025)

Inspire Medical Systems' Change in Account Payables history spans 9 years, with the latest figure at -$22.1 million for Q4 2025.

  • For Q4 2025, Change in Account Payables fell 657.89% year-over-year to -$22.1 million; the TTM value through Dec 2025 reached -$3.7 million, down 720.36%, while the annual FY2025 figure was -$3.7 million, 720.36% down from the prior year.
  • Change in Account Payables for Q4 2025 was -$22.1 million at Inspire Medical Systems, down from $6.5 million in the prior quarter.
  • Across five years, Change in Account Payables topped out at $21.3 million in Q2 2025 and bottomed at -$22.1 million in Q4 2025.
  • The 5-year median for Change in Account Payables is $1.6 million (2021), against an average of $1.3 million.
  • The largest annual shift saw Change in Account Payables surged 702.34% in 2021 before it plummeted 657.89% in 2025.
  • A 5-year view of Change in Account Payables shows it stood at $1.3 million in 2021, then surged by 346.39% to $5.8 million in 2022, then crashed by 130.92% to -$1.8 million in 2023, then soared by 322.65% to $4.0 million in 2024, then tumbled by 657.89% to -$22.1 million in 2025.
  • Per Business Quant, the three most recent readings for INSP's Change in Account Payables are -$22.1 million (Q4 2025), $6.5 million (Q3 2025), and $21.3 million (Q2 2025).